Xvivo Perfusion AB (publ) (FRA:3XV)

Xvivo Perfusion AB Statistics

Total Valuation

FRA:3XV has a market cap or net worth of EUR 471.63 million. The enterprise value is 457.53 million.

Market Cap	471.63M
Enterprise Value	457.53M

Important Dates

The next estimated earnings date is Tuesday, January 27, 2026.

Earnings Date	Jan 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	31.50M
Shares Outstanding	n/a
Shares Change (YoY)	+1.25%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.45%
Owned by Institutions (%)	32.16%
Float	25.05M

Valuation Ratios

The trailing PE ratio is 174.38 and the forward PE ratio is 50.65.

PE Ratio	174.38
Forward PE	50.65
PS Ratio	6.41
PB Ratio	2.49
P/TBV Ratio	3.65
P/FCF Ratio	n/a
P/OCF Ratio	68.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.53, with an EV/FCF ratio of -209.81.

EV / Earnings	169.17
EV / Sales	6.20
EV / EBITDA	36.53
EV / EBIT	74.07
EV / FCF	-209.81

Financial Position

The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.06.

Current Ratio	5.41
Quick Ratio	3.27
Debt / Equity	0.06
Debt / EBITDA	0.90
Debt / FCF	-5.17
Interest Coverage	0.59

Financial Efficiency

Return on equity (ROE) is 1.43% and return on invested capital (ROIC) is 1.97%.

Return on Equity (ROE)	1.43%
Return on Assets (ROA)	1.83%
Return on Invested Capital (ROIC)	1.97%
Return on Capital Employed (ROCE)	3.03%
Revenue Per Employee	367,947
Profits Per Employee	13,523
Employee Count	190
Asset Turnover	0.35
Inventory Turnover	0.86

Taxes

In the past 12 months, FRA:3XV has paid 1.55 million in taxes.

Income Tax	1.55M
Effective Tax Rate	36.36%

Stock Price Statistics

The stock price has decreased by -61.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.94%
50-Day Moving Average	15.77
200-Day Moving Average	23.92
Relative Strength Index (RSI)	38.12
Average Volume (20 Days)	9

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3XV had revenue of EUR 73.59 million and earned 2.70 million in profits. Earnings per share was 0.09.

Revenue	73.59M
Gross Profit	55.22M
Operating Income	6.16M
Pretax Income	4.25M
Net Income	2.70M
EBITDA	11.40M
EBIT	6.16M
Earnings Per Share (EPS)	0.09

Balance Sheet

The company has 25.32 million in cash and 11.26 million in debt, giving a net cash position of 14.06 million.

Cash & Cash Equivalents	25.32M
Total Debt	11.26M
Net Cash	14.06M
Net Cash Per Share	n/a
Equity (Book Value)	189.38M
Book Value Per Share	6.01
Working Capital	52.96M

Cash Flow

In the last 12 months, operating cash flow was 6.89 million and capital expenditures -9.08 million, giving a free cash flow of -2.18 million.

Operating Cash Flow	6.89M
Capital Expenditures	-9.08M
Free Cash Flow	-2.18M
FCF Per Share	n/a

Margins

Gross margin is 75.04%, with operating and profit margins of 8.37% and 3.68%.

Gross Margin	75.04%
Operating Margin	8.37%
Pretax Margin	5.78%
Profit Margin	3.68%
EBITDA Margin	15.49%
EBIT Margin	8.37%
FCF Margin	n/a

Dividends & Yields

FRA:3XV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.25%
Shareholder Yield	-1.25%
Earnings Yield	0.57%
FCF Yield	-0.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:3XV has an Altman Z-Score of 24.21 and a Piotroski F-Score of 6.

Altman Z-Score	24.21
Piotroski F-Score	6